실사 영역

Quality & Due Diligence

Buyer-oriented diligence on quality systems, documentation, traceability, supply-chain controls and execution readiness.

4

가이드

Formulation & Scale-Up

Navigating Lifecycle Impairment Mechanisms for Dietary Supplements and Functional Foods: From Formulation to Systemic Exposure

Buyers face significant risk from diverse formulation, processing, and physiological mechanisms that measurably impair the identity, potency, release, bioaccessibility, systemic exposure, or safety of dietary supplements and functional foods. This can lead to reduced efficacy and commercial failure if not addressed across the product lifecycle.

Dietary SupplementsFunctional FoodsDrug InteractionsBiological Availability

Formulation & Scale-Up

Optimizing Multi-Strain Probiotic Formulations: Addressing Viability, Delivery, and Efficacy Challenges

The formulation challenge is preventing significant strain-level viability loss and compromised clinical efficacy in multi-strain probiotics. Buyers must address degradation from moisture, manufacturing, and GI transit.

ProbioticsFormulationDrug StabilityCell Viability

Formulation & Scale-Up

Optimizing Lipophilic Active Softgels: Managing Oxidation, Stability, and Bioavailability Through Formulation and Packaging

Ensuring the long-term chemical and physical stability, dissolution performance, and oral bioavailability of lipophilic actives in softgels is challenged by complex interactions between fill composition, shell material, packaging, and supply-chain conditions.

SoftgelsLipidsOxidationBioavailability

출시 전략

건강기능식품 제조 타임라인: 제품 브리프에서 초도 상업 생산 배치까지의 핵심 경로(Critical Path)

구매자의 주요 리스크는 핵심 제품, 시장 및 규제 파라미터를 사전에 명확히 정의하지 않고 출시 일정, 클레임 또는 제형을 확정하여 막대한 재작업 비용이 발생하거나 시장 기회를 놓치게 되는 것입니다.

Dietary SupplementsManufacturing ProcessCritical Path PlanningRegulatory Compliance

복잡한 결정에는 명확한 범위 설정이 필요합니다

귀사의 특정 프로그램에 맞춘 제품 결정을 원하십니까?

본 가이드는 올바른 질문을 정립하는 데 도움을 줍니다. 제품별 제형, 시장, 근거 및 기술적 결정은 명확히 정의된 Paid Discovery 또는 맞춤형 FSMP 범위 내에서 이루어져야 합니다.